Document is current
Any future updates will be listed below
-
Authors
Snyder, Stella https://orcid.org/0000-0002-8061-3848
Secinti, Ekin https://orcid.org/0000-0001-7794-8500
Krueger, Ellen F. https://orcid.org/0000-0003-1553-9175
Adra, Nabil
Pili, Roberto
Hanna, Nasser H.
Mosher, Catherine E. https://orcid.org/0000-0002-9689-5392
-
Funding
Funding for this research was provided by:
National Cancer Institute, United States (T32CA117865)
Walther Cancer Foundation (0172.01)
- License Information
-
More Information
Article History
Received: 1 July 2024
Accepted: 24 December 2025
First Online: 3 January 2026
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Indiana University Institutional Review Board.
: Informed consent was obtained from all individual participants included in the study.
: Participants provided informed consent regarding publishing their data.
: Ekin Secinti is presently an employee and shareholder of Eli Lilly and Company, Indianapolis, IN. This study was not financially supported by and does not necessarily represent the official views of Eli Lilly and Company. The authors declare that they have no conflict of interest.
